Australian hemp company Elixinol Global (ASX: EXL) (OTC: ELLXF) shared Q2 financial results in a press release issued on July 30th, with sales of A$8.0 million growing 111% from...
Compass Cannabis Clinics Launches International Venture CALGARY, Alberta, June 11, 2018 (GLOBE NEWSWIRE) — 10330698 Canada Ltd. (dba Compass Cannabis Clinics, “Compass”) is pleased to announce that it has...
Exclusive Interview with Elixinol Global Founder and CEO Paul Benhaim Elixinol Global (ASX: EXL) (OTC: ELLXF), a parent company that includes hemp food, CBD, and medical cannabis businesses, has...
EDMONTON, April 30, 2018 /CNW/ – Aurora Cannabis Inc. (“Aurora” or the “Company”) (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) today responds to speculation published in the Australian...
Canopy Growth Launches Spectrum Australia with Support from the Victoria State Government SMITHS FALLS, ON and MELBOURNE, Australia, April 25, 2018 /CNW/ – Canopy Growth Corporation (TSX: WEED) (“Canopy...
Aphria’s Australian-based partner Althea receives Medical Cannabis License for cultivation Aphria maintains a 25% ownership interest in Althea and existing supply agreement LEAMINGTON, ON, March 15, 2018 /CNW/ –...
Exclusive interview with MedReleaf CEO and Co-Founder Neil Closner Neil Closner, CEO and Co-Founder of MedReleaf (TSX: LEAF) (OTC: MEDFF), believes his company has positioned itself as one of...
Indica Industries Pty Ltd, the partner of Canadian licensed producer MedReleaf (TSX: LEAF) (OTC: MEDFF) that is operating as MedReleaf Australia, has commenced commercial operations. The company, which received its...
Aurora Cannabis Provides Update on International Activities EDMONTON, Jan. 23, 2018 /CNW/ – Aurora Cannabis Inc. (“Aurora” or the “Company”) (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) is...
ABCANN GLOBAL CORPORATION (TSXV: ABCN) (“ABcann” or the “Company”) is pleased to announce that its wholly-owned subsidiary, ABcann Australia Pty Ltd. (“ABcann Australia”), has received an import license from...
Canopy Growth enters landmark research and production MOU with Australian Victoria State Government SMITHS FALLS, ON and VICTORIA, Australia, Jan. 16, 2018 /CNW/ – Canopy Growth Corporation (TSX: WEED)...
Elixinol Global Initial Public Offering (“IPO”) Elixinol Global Limited (the “Company”) is pleased to announce the successful completion of its initial public offering (“IPO”) of shares and its admission...
Australia-based Creso Pharma (ASX: CPH) (OTC: CRCPF) announced an expansion into Colombia, signing a deal to acquire licensed medical cannabis company Kunna Canada and its wholly owned subsidiary, Kunna...
Aurora Cannabis Increases Ownership Interest in Cann Group Ltd. Cann to Use Funds for Accelerated Expansion Aurora’s Neil Belot Appointed to Cann Board of Directors VANCOUVER and EDMONTON, Dec....
Cann Group ( ASX: CAN) (OTC: CNGGF) announced an increase to its capital raise, boosting it to $58.7, seling by shares $2.50 in a deal underwritten by Canaccord...
VANCOUVER, British Columbia, Nov. 14, 2017 (GLOBE NEWSWIRE) — Harvest One Cannabis Inc. (TSXV: HVST) (“Harvest One” or the “Company”) through its wholly owned Swiss subsidiary, Satipharm AG (“Satipharm”),...
CannTrust™ Announces Receiving Health Canada Approval to Export Medical Marijuana Internationally and the Shipping of Medical Marijuana to Australia VAUGHAN, ON, Nov. 8, 2017 /CNW/ – CannTrust Holdings...
Canopy Growth Provides Further International Updates SMITHS FALLS, ON, Sept. 13, 2017 /CNW/ – Canopy Growth Corporation (TSX: WEED) (OTC: TWMJF) (“Canopy Growth” or the “Company”) is pleased to...
Licensing & Distribution Agreement with Cannakorp for Cannabis Vaporization Technology 25 August 2017 – Cann Group Limited (ASX:CAN) has executed a licensing and distribution agreement with CannaKorp, Inc. to...
9 August 2017 Australian Manufacturing Licence Granted Significant milestone in Australian Operations AusCann has been granted an Australian medicinal cannabis manufacturing licence by the Office of Drug Control. The...
Aurora and Cann Group Execute Technical Services Agreement VANCOUVER and MELBOURNE, Australia, July 18, 2017 /CNW/ – Aurora Cannabis Inc. (the “Company” or “Aurora”) (TSXV: ACB) (OTCQX: ACBFF) (Frankfurt:...
VANCOUVER, July 13, 2017 /CNW/ – Aurora Cannabis Inc. (the “Company” or “Aurora”) (TSXV: ACB) (OTCQX: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) is pleased to announce that today the Company...
AusCann – Tasmanian Alkaloids Licenses Secured Australian medicinal cannabis licence, and a research and development licence, granted to AusCann’s strategic partner Tasmanian Alkaloids The licences are a significant milestone in...
LeafCann Group and Resolve Digital Health Inc. Partner to Expand Australian Medical Cannabis Market Agreement Paves Way for Significant Canadian-Australia Medical Cannabis Collaboration TORONTO and MELBOURNE, Australia, June 27,...
AusCann Secures $12 Million In Institutional Placement 19 May 2017 Highlights Successful Placement raising $12 million with strong interest from new institutional investors both domestic and global 24,000,000 shares...
